IP Verse

Formoterol Superfine Formulation - EP3384931

The patent EP3384931 was granted to Chiesi Farmaceutici on Jul 24, 2019. The application was originally filed on Feb 26, 2003 under application number EP18173392A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3384931

CHIESI FARMACEUTICI
Application Number
EP18173392A
Filing Date
Feb 26, 2003
Status
Granted And Under Opposition
Jun 21, 2019
Grant Date
Jul 24, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LUPIN HEALTHCARE UKApr 23, 2020DEHNSWITHDRAWN

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP1157689
OPPOSITIONUS6004537
SEARCHEP1157689
SEARCHUS6004537
SEARCHWO0051591

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Ethanol", anonymous, British Pharmacopeia, (20020000), pages 700 - 705, XP055706344-
OPPOSITION- "Experimental Report: Effect of manufacture process on water content", Chiesi Farmaceutici SpA, (20170310), XP055485445-
OPPOSITION- "Manufacture and Evaluation of Metered-Dose Inhalers", Hickey, Anthony J., Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, Inc, (1992), pages 175 - 177, XP055706339-
OPPOSITION- LEACH, C.L., "Improved delivery of inhaled steroids to the large and small airways", Respiratory Medicine, (19980600), vol. 92, no. Supp A, pages 3 - 8, XP055706349
OPPOSITION- KIRSCH et al., "Development of a Lyophilized Formulation for (R,R)-Formoterol(L)-Tartrate", Drug Development and Industrial Pharmacy, (20010101), vol. 27, no. 1, pages 89 - 96, XP001091202
SEARCH- Chiesi Farmaceutici S.P.A., "Experimental Report "Effect of manufacture process of water content"", Experimental Report "Effect of manufacture process of water content", (20170310), XP055485445 [T] * the whole document *-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents